5.77
1.76%
0.10
Handel nachbörslich:
5.85
0.08
+1.39%
Schlusskurs vom Vortag:
$5.67
Offen:
$5.77
24-Stunden-Volumen:
23,117
Relative Volume:
0.18
Marktkapitalisierung:
$46.61M
Einnahmen:
$442.00K
Nettoeinkommen (Verlust:
$-30.46M
KGV:
-9.459
EPS:
-0.61
Netto-Cashflow:
$-27.47M
1W Leistung:
-9.56%
1M Leistung:
+8.87%
6M Leistung:
-33.66%
1J Leistung:
-28.61%
Clene Inc Stock (CLNN) Company Profile
Firmenname
Clene Inc
Sektor
Branche
Telefon
801-676-9695
Adresse
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Clene Inc Stock (CLNN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2022-10-04 | Herabstufung | Oppenheimer | Outperform → Perform |
2022-07-18 | Eingeleitet | H.C. Wainwright | Buy |
2022-05-02 | Eingeleitet | Canaccord Genuity | Buy |
2021-09-28 | Eingeleitet | Oppenheimer | Outperform |
Clene Inc Aktie (CLNN) Neueste Nachrichten
Clene to Meet with FDA Leadership to Discuss CNM-Au8 Biomarker for ALS Treatment - Vancity Buzz
IBN Coverage: Clene (NASDAQ: CLNN) Set to Discuss Lead Candidate Biomarker With FDA Leadership - Yahoo Finance
Clene (NASDAQ: CLNN) Set to Discuss Lead Candidate Biomarker with FDA Leadership - The Globe and Mail
Clene Unveils Phase 3 Trial Design at NEALS - TipRanks
Clene Showcases Progress on CNM-Au8 for Neurodegenerative Diseases at Investor Conferences - Vancity Buzz
IBN Coverage: Clene (NASDAQ: CLNN) Presents Lead Candidate CNM-Au8(R) Updates at Investor Conferences - Yahoo Finance
Clene Inc (CLNN-Q) QuotePress Release - The Globe and Mail
(CLNN) Trading Report - Stock Traders Daily
IBN Coverage: Clene (NASDAQ: CLNN) Closes $7.3M Registered Direct Offering and Concurrent Private Placements - Yahoo Finance
Clene Secures $7.3M in Funding to Advance Neurodegenerative Disease Treatment - Vancity Buzz
Canaccord retains price target, buy rating on Clene shares post-webinar - Investing.com Canada
IBN Coverage: Clene (NASDAQ: CLNN) Announces Participation at Two Upcoming Investor Conferences - Yahoo Finance
Clene Inc. to Present at Two Upcoming Investor Conferences in October - Vancity Buzz
Clene to Present at Upcoming October Conferences - The Manila Times
Clene (NASDAQ:CLNN) Price Target Cut to $86.00 by Analysts at Canaccord Genuity Group - Defense World
Independent Chairman of the Board of Clene Picks Up 26% More Stock - Simply Wall St
Independent Chairman of the Board of Clene David Matlin Buys 26% More Shares - Yahoo Finance
Canaccord cuts Clene stock price target, maintains Buy rating By Investing.com - Investing.com South Africa
Canaccord cuts Clene stock price target, maintains Buy rating - Investing.com
Clene Secures $7.3 Million in Funding Through Direct Offering and Private Placements - Vancity Buzz
IBN Coverage: Clene (NASDAQ: CLNN) Closes on Direct Offering, Concurrent Private Placements Totaling $7.3M - Yahoo Finance
Clene Inc. director David Matlin buys $438k in company stock - Investing.com
Clene Inc. CEO purchases $47,500 in company stock - Investing.com India
Clene Inc. chief science officer purchases $97,432 in company stock By Investing.com - Investing.com Australia
Clene Inc. chief science officer purchases $97,432 in company stock - Investing.com India
IBN Coverage: Clene (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements - Yahoo Finance
Clene (CLNN) Gains Momentum In The Extended Session After Completing Investment Offering - Stocks Telegraph
Clene Announces Closing of $7.3 Million Registered Direct Offering and Concurrent Private Placements and Amendment of Debt Facility - The Manila Times
Clene Inc. CEO purchases $47,500 in company stock By Investing.com - Investing.com Australia
Insider Buying: Chief Science Officer Mark Mortenson Acquires Sh - GuruFocus.com
Clene Inc. Secures $7.3 Million in Funding Through Direct Offerings and Private Placements - Vancity Buzz
Clene (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements - The Globe and Mail
Clene Inc. secures $7.3 million in stock and warrant sales By Investing.com - Investing.com Australia
Clene Inc. modifies loan terms and adjusts warrant exercise price - Investing.com India
Clene Inc. modifies loan terms and adjusts warrant exercise price By Investing.com - Investing.com Canada
Clene Inc. secures $7.3 million in stock and warrant sales - Investing.com India
Clene launches $7.3M registered direct offering - Seeking Alpha
Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules - The Manila Times
Clene Inc. announced that it expects to receive $3.810506 million in funding - Marketscreener.com
Clene (NASDAQ:CLNN) Stock Quotes, Forecast and News Summary - Benzinga
IBN Coverage: Clene (NASDAQ: CLNN) to Discuss CNM-Au8(R) Data FDA Leadership - Yahoo Finance
Clene to Meet with FDA Leadership to Discuss CNM-Au8 Data for ALS Treatment - Vancity Buzz
The Globe and Mail - The Globe and Mail
Finanzdaten der Clene Inc-Aktie (CLNN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):